Immunohematology Market Size, Trends, Analysis, and Outlook By Products (Immunohematology Analyzers, Immunohematology Reagents), By Application (Blood Typing, Antibody Screening), By End-User (Hospitals, Diagnostic Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Immunohematology market size is poised to register 4.88% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Immunohematology market across By Products (Immunohematology Analyzers, Immunohematology Reagents), By Application (Blood Typing, Antibody Screening), By End-User (Hospitals, Diagnostic Laboratories, Others).
The immunohematology market is witnessing notable growth propelled by the increasing demand for blood transfusions, rising prevalence of blood disorders and trauma cases, and advancements in blood typing and crossmatching technologies. In 2024 and beyond, factors such as the growing emphasis on blood safety and compatibility testing, expansion of blood banks and transfusion centers, and rising awareness of alloimmunization risks drive market expansion. Additionally, the development of fully automated immunohematology analyzers, adoption of molecular blood typing methods for rare blood group identification, and collaborations between blood centers and diagnostic manufacturers contribute to market growth.
Immunohematology Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Immunohematology market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Immunohematology survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Immunohematology industry.
Key market trends defining the global Immunohematology demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Immunohematology Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Immunohematology industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Immunohematology companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Immunohematology industry
Leading Immunohematology companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Immunohematology companies.
Immunohematology Market Study- Strategic Analysis Review
The Immunohematology market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Immunohematology industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Immunohematology Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Immunohematology Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Immunohematology market segments. Similarly, Strong end-user demand is encouraging Canadian Immunohematology companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Immunohematology market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Immunohematology Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Immunohematology industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Immunohematology market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Immunohematology Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Immunohematology in Asia Pacific. In particular, China, India, and South East Asian Immunohematology markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Immunohematology Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Immunohematology Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Immunohematology market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Immunohematology.
Immunohematology Market Company Profiles
The global Immunohematology market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, Beckman Coulter Inc (Danaher Corp), Becton Dickinson and Company, Bio-Rad Laboratories Inc, Cardinal Health, F. Hoffmann La-Roche Ltd, Grifols S.A., Immucor Inc, Merck KGaA, Ortho Clinical Diagnostics, Siemens Healthineers, Thermo Fisher Scientific
Recent Immunohematology Market Developments
The global Immunohematology market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Immunohematology Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Products
Immunohematology Analyzers
Immunohematology Reagents
By Application
Blood Typing
Antibody Screening
By End-User
Hospitals
Diagnostic Laboratories
Others
Geographical Segmentation:
Abbott Laboratories
Beckman Coulter Inc (Danaher Corp)
Becton Dickinson and Company
Bio-Rad Laboratories Inc
Cardinal Health
F. Hoffmann La-Roche Ltd
Grifols S.A.
Immucor Inc
Merck KGaA
Ortho Clinical Diagnostics
Siemens Healthineers
Thermo Fisher Scientific
Formats Available: Excel, PDF, and PPT
The immunohematology market is witnessing notable growth propelled by the increasing demand for blood transfusions, rising prevalence of blood disorders and trauma cases, and advancements in blood typing and crossmatching technologies. In 2024 and beyond, factors such as the growing emphasis on blood safety and compatibility testing, expansion of blood banks and transfusion centers, and rising awareness of alloimmunization risks drive market expansion. Additionally, the development of fully automated immunohematology analyzers, adoption of molecular blood typing methods for rare blood group identification, and collaborations between blood centers and diagnostic manufacturers contribute to market growth.
Immunohematology Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Immunohematology market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Immunohematology survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Immunohematology industry.
Key market trends defining the global Immunohematology demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Immunohematology Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Immunohematology industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Immunohematology companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Immunohematology industry
Leading Immunohematology companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Immunohematology companies.
Immunohematology Market Study- Strategic Analysis Review
The Immunohematology market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Immunohematology industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Immunohematology Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Immunohematology Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Immunohematology market segments. Similarly, Strong end-user demand is encouraging Canadian Immunohematology companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Immunohematology market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Immunohematology Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Immunohematology industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Immunohematology market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Immunohematology Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Immunohematology in Asia Pacific. In particular, China, India, and South East Asian Immunohematology markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Immunohematology Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Immunohematology Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Immunohematology market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Immunohematology.
Immunohematology Market Company Profiles
The global Immunohematology market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, Beckman Coulter Inc (Danaher Corp), Becton Dickinson and Company, Bio-Rad Laboratories Inc, Cardinal Health, F. Hoffmann La-Roche Ltd, Grifols S.A., Immucor Inc, Merck KGaA, Ortho Clinical Diagnostics, Siemens Healthineers, Thermo Fisher Scientific
Recent Immunohematology Market Developments
The global Immunohematology market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Immunohematology Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Products
Immunohematology Analyzers
Immunohematology Reagents
By Application
Blood Typing
Antibody Screening
By End-User
Hospitals
Diagnostic Laboratories
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abbott Laboratories
Beckman Coulter Inc (Danaher Corp)
Becton Dickinson and Company
Bio-Rad Laboratories Inc
Cardinal Health
F. Hoffmann La-Roche Ltd
Grifols S.A.
Immucor Inc
Merck KGaA
Ortho Clinical Diagnostics
Siemens Healthineers
Thermo Fisher Scientific
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Immunohematology Market Overview and Key Findings, 2024
1.2 Immunohematology Market Size and Growth Outlook, 2021- 2030
1.3 Immunohematology Market Growth Opportunities to 2030
1.4 Key Immunohematology Market Trends and Challenges
1.4.1 Immunohematology Market Drivers and Trends
1.4.2 Immunohematology Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Immunohematology Companies
2. IMMUNOHEMATOLOGY MARKET SIZE OUTLOOK TO 2030
2.1 Immunohematology Market Size Outlook, USD Million, 2021- 2030
2.2 Immunohematology Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. IMMUNOHEMATOLOGY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. IMMUNOHEMATOLOGY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products
Immunohematology Analyzers
Immunohematology Reagents
By Application
Blood Typing
Antibody Screening
By End-User
Hospitals
Diagnostic Laboratories
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Immunohematology Market, 2025
5.2 Asia Pacific Immunohematology Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Immunohematology Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Immunohematology Market, 2025
5.5 Europe Immunohematology Market Size Outlook by Type, 2021- 2030
5.6 Europe Immunohematology Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Immunohematology Market, 2025
5.8 North America Immunohematology Market Size Outlook by Type, 2021- 2030
5.9 North America Immunohematology Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Immunohematology Market, 2025
5.11 South America Pacific Immunohematology Market Size Outlook by Type, 2021- 2030
5.12 South America Immunohematology Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Immunohematology Market, 2025
5.14 Middle East Africa Immunohematology Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Immunohematology Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Immunohematology Market Size Outlook and Revenue Growth Forecasts
6.2 US Immunohematology Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Immunohematology Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Immunohematology Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Immunohematology Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Immunohematology Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Immunohematology Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Immunohematology Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Immunohematology Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Immunohematology Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Immunohematology Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Immunohematology Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Immunohematology Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Immunohematology Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Immunohematology Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Immunohematology Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Immunohematology Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Immunohematology Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Immunohematology Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Immunohematology Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Immunohematology Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Immunohematology Industry Drivers and Opportunities
7. IMMUNOHEMATOLOGY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. IMMUNOHEMATOLOGY COMPANY PROFILES
8.1 Profiles of Leading Immunohematology Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
Beckman Coulter Inc (Danaher Corp)
Becton Dickinson and Company
Bio-Rad Laboratories Inc
Cardinal Health
F. Hoffmann La-Roche Ltd
Grifols S.A.
Immucor Inc
Merck KGaA
Ortho Clinical Diagnostics
Siemens Healthineers
Thermo Fisher Scientific
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Immunohematology Market Overview and Key Findings, 2024
1.2 Immunohematology Market Size and Growth Outlook, 2021- 2030
1.3 Immunohematology Market Growth Opportunities to 2030
1.4 Key Immunohematology Market Trends and Challenges
1.4.1 Immunohematology Market Drivers and Trends
1.4.2 Immunohematology Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Immunohematology Companies
2. IMMUNOHEMATOLOGY MARKET SIZE OUTLOOK TO 2030
2.1 Immunohematology Market Size Outlook, USD Million, 2021- 2030
2.2 Immunohematology Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. IMMUNOHEMATOLOGY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. IMMUNOHEMATOLOGY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products
Immunohematology Analyzers
Immunohematology Reagents
By Application
Blood Typing
Antibody Screening
By End-User
Hospitals
Diagnostic Laboratories
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Immunohematology Market, 2025
5.2 Asia Pacific Immunohematology Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Immunohematology Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Immunohematology Market, 2025
5.5 Europe Immunohematology Market Size Outlook by Type, 2021- 2030
5.6 Europe Immunohematology Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Immunohematology Market, 2025
5.8 North America Immunohematology Market Size Outlook by Type, 2021- 2030
5.9 North America Immunohematology Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Immunohematology Market, 2025
5.11 South America Pacific Immunohematology Market Size Outlook by Type, 2021- 2030
5.12 South America Immunohematology Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Immunohematology Market, 2025
5.14 Middle East Africa Immunohematology Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Immunohematology Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Immunohematology Market Size Outlook and Revenue Growth Forecasts
6.2 US Immunohematology Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Immunohematology Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Immunohematology Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Immunohematology Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Immunohematology Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Immunohematology Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Immunohematology Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Immunohematology Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Immunohematology Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Immunohematology Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Immunohematology Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Immunohematology Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Immunohematology Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Immunohematology Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Immunohematology Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Immunohematology Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Immunohematology Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Immunohematology Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Immunohematology Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Immunohematology Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Immunohematology Industry Drivers and Opportunities
7. IMMUNOHEMATOLOGY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. IMMUNOHEMATOLOGY COMPANY PROFILES
8.1 Profiles of Leading Immunohematology Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
Beckman Coulter Inc (Danaher Corp)
Becton Dickinson and Company
Bio-Rad Laboratories Inc
Cardinal Health
F. Hoffmann La-Roche Ltd
Grifols S.A.
Immucor Inc
Merck KGaA
Ortho Clinical Diagnostics
Siemens Healthineers
Thermo Fisher Scientific
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
